Redcare Pharmacy (0RJT) Ratios
Redcare Pharmacy Ratios
GB:0RJT's free cash flow for Q3 2026 was $20.50M. For the 2026 fiscal year, GB:0RJT's free cash flow was decreased by $-13.70M and operating cash flow was $34.20M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.55 | 2.00 | 2.23 | 2.88 | 3.49 |
| Quick Ratio | 1.01 | 1.39 | 1.63 | 2.05 | 2.71 |
| Cash Ratio | 0.23 | 0.39 | 0.38 | 0.56 | 1.99 |
| Solvency Ratio | 0.04 | 0.05 | 0.10 | -0.10 | -0.13 |
| Operating Cash Flow Ratio | 0.06 | 0.09 | 0.27 | -0.24 | 0.09 |
| Short-Term Operating Cash Flow Coverage | 0.27 | 13.62 | 37.82 | -17.47 | 7.00 |
| Net Current Asset Value | $ -147.90M | $ 6.71M | $ 29.95M | $ -30.93M | $ 65.10M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.33 | 0.25 | 0.24 | 0.35 | 0.30 |
| Debt-to-Equity Ratio | 0.91 | 0.51 | 0.47 | 0.72 | 0.57 |
| Debt-to-Capital Ratio | 0.48 | 0.34 | 0.32 | 0.42 | 0.36 |
| Long-Term Debt-to-Capital Ratio | 0.36 | 0.30 | 0.28 | 0.38 | 0.33 |
| Financial Leverage Ratio | 2.71 | 2.07 | 1.96 | 2.06 | 1.89 |
| Debt Service Coverage Ratio | 0.51 | 3.14 | 3.14 | -2.38 | -3.30 |
| Interest Coverage Ratio | -1.17 | -5.01 | -1.12 | -8.13 | -7.67 |
| Debt to Market Cap | 0.27 | 0.08 | 0.08 | 0.28 | 0.10 |
| Interest Debt Per Share | 21.68 | 12.72 | 13.53 | 14.66 | 13.70 |
| Net Debt to EBITDA | 7.09 | 5.37 | 3.15 | -6.16 | 0.28 |
| Profitability Margins | |||||
| Gross Profit Margin | 20.19% | 23.02% | 24.48% | 27.55% | 25.14% |
| EBIT Margin | -0.81% | -1.69% | -0.35% | -5.83% | -6.07% |
| EBITDA Margin | 1.55% | 1.18% | 2.83% | -2.54% | -3.53% |
| Operating Profit Margin | -0.81% | -1.64% | -0.96% | -5.74% | -6.20% |
| Pretax Profit Margin | -1.62% | -2.02% | -0.80% | -6.98% | -7.35% |
| Net Profit Margin | -1.28% | -1.92% | -0.67% | -6.45% | -7.00% |
| Continuous Operations Profit Margin | -1.34% | -1.96% | -0.65% | -6.45% | -7.00% |
| Net Income Per EBT | 79.04% | 95.05% | 83.92% | 92.30% | 95.25% |
| EBT Per EBIT | 200.42% | 122.69% | 82.96% | 121.61% | 118.55% |
| Return on Assets (ROA) | -3.02% | -4.53% | -1.18% | -10.64% | -9.47% |
| Return on Equity (ROE) | -8.21% | -9.39% | -2.31% | -21.89% | -17.86% |
| Return on Capital Employed (ROCE) | -2.81% | -5.17% | -2.17% | -11.34% | -9.97% |
| Return on Invested Capital (ROIC) | -2.11% | -4.95% | -1.73% | -10.34% | -9.40% |
| Return on Tangible Assets | -4.42% | -7.68% | -2.03% | -17.63% | -14.11% |
| Earnings Yield | -2.88% | -1.72% | -0.48% | -9.79% | -3.66% |
| Efficiency Ratios | |||||
| Receivables Turnover | 19.25 | 21.58 | 17.44 | 29.41 | 29.32 |
| Payables Turnover | 9.46 | 10.41 | 8.94 | 12.66 | 10.16 |
| Inventory Turnover | 10.97 | 11.86 | 10.00 | 8.75 | 8.22 |
| Fixed Asset Turnover | 15.42 | 28.71 | 20.70 | 14.10 | 13.55 |
| Asset Turnover | 2.36 | 2.36 | 1.76 | 1.65 | 1.35 |
| Working Capital Turnover Ratio | 12.52 | 9.01 | 7.19 | 4.52 | 4.34 |
| Cash Conversion Cycle | 13.68 | 12.62 | 16.57 | 25.28 | 20.96 |
| Days of Sales Outstanding | 18.96 | 16.92 | 20.93 | 12.41 | 12.45 |
| Days of Inventory Outstanding | 33.28 | 30.77 | 36.49 | 41.71 | 44.43 |
| Days of Payables Outstanding | 38.57 | 35.06 | 40.84 | 28.84 | 35.92 |
| Operating Cycle | 52.24 | 47.68 | 57.41 | 54.12 | 56.88 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.14 | 1.10 | 3.19 | -1.62 | 0.65 |
| Free Cash Flow Per Share | -2.80 | 0.67 | 1.21 | -4.59 | -1.76 |
| Dividend Paid and CapEx Coverage Ratio | 0.29 | 2.53 | 1.61 | -0.54 | 0.27 |
| Capital Expenditure Coverage Ratio | 0.29 | 2.53 | 1.61 | -0.54 | 0.27 |
| Operating Cash Flow Coverage Ratio | 0.06 | 0.09 | 0.25 | -0.11 | 0.05 |
| Operating Cash Flow to Sales Ratio | 0.01 | 0.01 | 0.03 | -0.02 | 0.01 |
| Free Cash Flow Yield | -4.30% | 0.51% | 0.92% | -10.42% | -1.56% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -34.81 | -58.02 | -210.18 | -10.22 | -27.31 |
| Price-to-Sales (P/S) Ratio | 0.45 | 1.11 | 1.41 | 0.66 | 1.91 |
| Price-to-Book (P/B) Ratio | 2.85 | 5.46 | 4.85 | 2.24 | 4.88 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -23.25 | 197.36 | 108.92 | -9.60 | -64.27 |
| Price-to-Operating Cash Flow Ratio | 56.92 | 119.37 | 41.18 | -27.25 | 174.14 |
| Price-to-Earnings Growth (PEG) Ratio | 1.98 | -0.22 | 2.46 | -2.49 | -0.11 |
| Enterprise Value Multiple | 35.80 | 99.60 | 52.84 | -32.05 | -53.87 |
| Enterprise Value | 1.63B | 2.79B | 2.69B | 982.07M | 2.02B |
| EV to EBITDA | 35.80 | 99.60 | 52.84 | -32.05 | -53.87 |
| EV to Sales | 0.56 | 1.18 | 1.50 | 0.82 | 1.90 |
| EV to Free Cash Flow | -28.99 | 208.61 | 115.84 | -11.88 | -63.94 |
| EV to Operating Cash Flow | 70.97 | 126.17 | 43.80 | -33.73 | 173.23 |
| Tangible Book Value Per Share | 4.26 | 4.92 | 6.44 | 3.65 | 8.83 |
| Shareholders’ Equity Per Share | 22.84 | 24.13 | 27.14 | 19.72 | 23.23 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.17 | 0.03 | 0.19 | 0.08 | 0.05 |
| Revenue Per Share | 146.25 | 118.21 | 93.50 | 66.96 | 59.29 |
| Net Income Per Share | -1.87 | -2.27 | -0.63 | -4.32 | -4.15 |
| Tax Burden | 0.79 | 0.95 | 0.84 | 0.92 | 0.95 |
| Interest Burden | 2.00 | 1.19 | 2.26 | 1.20 | 1.21 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.15 | 0.25 | 0.02 | 0.02 | 0.02 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 |
| Income Quality | -0.81 | -0.49 | -5.10 | 0.42 | -0.18 |
Currency in EUR